AVITA Medical (RCEL) Receivables - Net (2018 - 2025)

AVITA Medical's Receivables - Net history runs 8 years deep, the most recent figure standing at $9.0 million for Q3 2025.

• Quarterly Receivables - Net fell 12.39% year-over-year to $9.0 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $9.0 million (down 12.39% YoY) and the FY2025 annual result came in at $9.1 million, down 22.91% from the prior year.
• Receivables - Net was $9.0 million for Q3 2025 at AVITA Medical, down from $11.3 million in the prior quarter.
• Across five years, Receivables - Net topped out at $12.0 million in Q1 2025 and bottomed at $2.2 million in Q1 2021.
• A 5-year average of $6.6 million and a median of $5.9 million in 2023 frame the typical range for Receivables - Net.
• Annual changes were most pronounced in 2024 — Receivables - Net soared 75.11% — and 2025, when it fell 12.39%.
• AVITA Medical's Receivables - Net stood at $3.1 million in 2021, then gained by 13.95% to $3.6 million in 2022, then jumped by 115.71% to $7.7 million in 2023, then jumped by 53.78% to $11.8 million in 2024, then declined by 23.53% to $9.0 million in 2025.
• Business Quant data shows RCEL's Receivables - Net at $9.0 million in Q3 2025, $11.3 million in Q2 2025, and $12.0 million in Q1 2025.